A Safety Study in Participants With Advanced Solid Tumors
Status:
Terminated
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine a safe dose of LY573636 (tasisulam) when used in 5
separate combinations with an approved cancer medication for treating participants with
advanced cancer. Data from this study will be reviewed for any side effects or anti-tumor
activity that may be associated with the LY573636 combination treatments.